Targeting Bruton Tyrosine Kinase With Zanubrutinib for Treatment of Vitreoretinal Lymphoma: Report of 3 Cases

Vitreoretinal lymphoma (VRL) is a rare intraocular malignancy, and standard treatment approaches have not been defined yet. Bruton tyrosine kinase inhibitors are found to be effective in the treatment of primary central nervous system diffuse large B cell lymphoma. Herein, we retrospectively reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liang, Guan, Wenxue, Peng, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103197/
https://www.ncbi.nlm.nih.gov/pubmed/33968786
http://dx.doi.org/10.3389/fonc.2021.676792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103197/
https://www.ncbi.nlm.nih.gov/pubmed/33968786
http://dx.doi.org/10.3389/fonc.2021.676792

Ejemplares similares